Skin Conditions

• Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis(PubMed)
• Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (PubMed)
• The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities (PubMed)
• Epigenetic control of skin differentiation genes by phytocannabinoids (PubMed)
• A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ(PubMed)
• Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1(PubMed)
• Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation (PubMed)
• Attenuation of allergic contact dermatitis through the endocannabinoid system (PubMed)
• Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus (PubMed)